Science & Technology
Science and Technology
Science and Technology
Tue, November 22, 2011 Direction of Market Influences - Report Highlights Acme Packet, Inc. and Regeneron Pharmaceuticals, Inc.
November 22, 2011 09:00 ET
Direction of Market Influences - Report Highlights Acme Packet, Inc. and Regeneron Pharmaceuticals, Inc.
NEW YORK, NY--(Marketwire - Nov 22, 2011) - Today, [ www.BrightonMarkets.com ] announced new reports highlighting Acme Packet, Inc. (
Upcoming macro-economic 'tides of influence' are buoyed by crisis both home and abroad. Spanish and Italian yields continue to climb as efforts by the European Central Bank have stopped short of establishing sovereign bond guarantees for any one country. The result is historic yields and a grave concern for the solvency of interbank lending. Markets were drawn to concerns over domestic policy stalemates producing downgrade risks. Despite the situation, there continues to be unique value and opportunity found within careful discretion.
Brighton Markets is releasing new coverage on Acme Packet, Inc. for its current position within the technology industry. Acme Packet, Inc. is a provider in session border control solutions, which enable the delivery interactive communications, such as voice, video and multimedia sessions, and data services across Internet protocol (IP), network borders. The full research report on Acme Packet, Inc. (
Brighton Markets has released research on Regeneron Pharmaceuticals, Inc. for its changing role within the healthcare industry. Regeneron Pharmaceuticals, Inc. (Regeneron) is a biopharmaceutical company. Regeneron discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The full research report on Regeneron Pharmaceuticals, Inc. (
About Brighton Markets
Brighton Markets was founded on the guiding principle of providing highly relevant, meaningful, and actionable information direct to investors. Across the investment spectrum, Brighton Markets shines light on today's events.
